期刊文献+
共找到788篇文章
< 1 2 40 >
每页显示 20 50 100
Clinical effects of psychological intervention and drug therapy against peptic ulcer 被引量:15
1
作者 Duo-Yu Wu Min Guo +6 位作者 Yun-Suo Gao Yan-Hai Kang Jun-Cheng Guo Xiang-Ling Jiang Feng Chen Tao Liu Min Li 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2012年第10期831-833,共3页
Objective:To evaluate the clinical effects of psychological interventions and drug therapy against peptic ulcer.Methods:96 patients with peptic ulcer were divided into control group with Tagamet 800 mg per evening p.o... Objective:To evaluate the clinical effects of psychological interventions and drug therapy against peptic ulcer.Methods:96 patients with peptic ulcer were divided into control group with Tagamet 800 mg per evening p.o.and trial group with psychological intervention on the basis of drug treatment.Results:There were significant differences between the two groups(P【0.05), the trial group showed that the anxiety and depression cases declined obviously and effective rate of ulcer therapy was much higlier than control group.Conclusions:In sum,psychological intervention combined with drug therapy provides an effective method for ulcer treatment. 展开更多
关键词 PSYCHOLOGICAL INTERVENTION drug therapy PEPTIC ulcer
下载PDF
Current medical therapy for ulcerative colitis 被引量:16
2
作者 XU Chang Tai and PAN Bo Rong 《World Journal of Gastroenterology》 SCIE CAS CSCD 1999年第1期69-77,共9页
NTRODUCTIONInrecentyears,theadvancesintherapyofulcerativecolitis(UC)havebeencharacterizedmainlybythemoreext... NTRODUCTIONInrecentyears,theadvancesintherapyofulcerativecolitis(UC)havebeencharacterizedmainlybythemoreextensiveuseofimmuno... 展开更多
关键词 colitis ulcerative/drug therapy inflammatory bowel diseases/drug therapy CYCLOSPORIN GLUCOCORTICOSTEROIDS SULPHASALAZINE 5 aminosalicylic acids
下载PDF
Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer 被引量:4
3
作者 Vladimir T.Ivashkin Tatiana L.Lapina +6 位作者 Oksana Yu.Bondarenko Olga A. Sklanskaya Petr Va.Grigoriev Yuri V.Vasiliev Emilia P.Yakovenko Pavel V.Gulyaev Valeri I.Fedchenko 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第5期879-882,共4页
AIM:To assess and compare the efficacy and safety of two triple regimes:A)metronidazole,amoxicillin and omeprazole, which is still widely used in Russia,and B)azithromycin, amoxicillin and omeprazole in healing active... AIM:To assess and compare the efficacy and safety of two triple regimes:A)metronidazole,amoxicillin and omeprazole, which is still widely used in Russia,and B)azithromycin, amoxicillin and omeprazole in healing active duodenal ulcer and H.pylori eradication. METHODS:100 patients with active duodenal ulcer were included in the open,multicentre,randomized study with comparative groups.Patients were randomly assigned to one of the following one-week triple regimes:A) metronidazole 500 mg bid,amoxicillin I g bid and omeprazole 20 mg bid(OAM,n=50)and B)azithromycin 1 god for the first 3 days(total dose 3 g),amoxicillin 1 g bid and omeprazole 20 mg bid(OAA,n=50).Omeprazole 20 mg od was given after the eradication course as a monotherapy for three weeks.The control endoscopy was performed 8 weeks after the entry.H.pyloriinfection was determined in the entry of the study and four weeks after the cessation of treatment by means of histology and CLO-test. RESULTS:97 patients completed the study according to the protocol(1 patient of the OAM group did not come to the control endoscopy,2 patients of the OAA group stopped the treatment because of mild allergic urticaria).Duodenal ulcers were healed in 48 patients of the OAM group(96 %, C190.5-100 %)and in 46 patients of the OAA group(92 %, CI 89.5-94.5 %)(p=ns).H.pyloHinfection was eradicated in 15 out of 50 patients with OAM(30 %,CI 17-43 %)and in 36 out of 50 patients treated with OAA(72 %;CI 59-85 %) (P<0.001)-ITT analysis.CONCLUSION: The triple therapy with omeprazole, amoxicillin and metronidazole failed to eradicate H.pylori'vc\ the majority of patients, which is an essential argument to withdraw this regimen out of the national recommendations. Macrolide with amoxicillin are preferable to achieve higher eradication rates. Azithromycin (1 g od for the first 3 days) can be considered as a successful component of the triple PPI-based regimen. 展开更多
关键词 Helicobacter pylori Adolescent Adult Aged AMOXICILLIN dosage Anti-Bacterial Agents Anti-ulcer Agents AZITHROMYCIN Comparative Study drug therapy Combination Duodenal ulcer Female Helicobacter Infections Humans Male METRONIDAZOLE Middle Aged OMEPRAZOLE PENICILLINS Research Support Non-U.S. Gov't Treatment Outcome
下载PDF
Experimental study on effect of recombinant human growth hormone combined with chemotherapy on stomach neoplasms implanted in nude mice 被引量:1
4
作者 Fangfang Shi Suyi Li 《The Chinese-German Journal of Clinical Oncology》 CAS 2007年第1期27-31,共5页
Objective: To investigate the effect of different doses of recombined growth hormone (rhGH) on stomach neo- plasms implanted in nude mice, and its efficacy in combining with chemotherapy (flurouracil, 5-FU). Methods: ... Objective: To investigate the effect of different doses of recombined growth hormone (rhGH) on stomach neo- plasms implanted in nude mice, and its efficacy in combining with chemotherapy (flurouracil, 5-FU). Methods: Human stom- ach neoplasms model was established in nude mice. The nude mice were divided into control group, moderate-dose of rhGH group, low-dose rhGH group, 5-FU group, moderate-dose rhGH/5-FU group, and low-dose rhGH/5-FU group. The results of each group were observed after ten days. Results: After therapy, the body mass of rhGH groups was significantly increased compared with control group (P<0.05), the body mass of rhGH/5-FU groups was significantly increased compared with 5-FU group (P<0.05), but it was no significant difference between rhGH/5-FU groups and control group (P>0.05). The average tumor mass and volume of rhGH groups were not significantly increased compared with control group (P>0.05), but they were significantly reduced in 5-FU group and rhGH/5-FU groups (P<0.05). They were no significant difference between rhGH/5- FU groups and 5-FU group (P>0.05). After treatment, the percentages of S, G0/G1 and G2/M phases and proliferation index (PI) were not significantly changed in rhGH groups compared with control group (P>0.05), and the same with rhGH/5-FU groups compared with 5-FU group (P>0.05). The difference caused by dose of rhGH was not significant. Conclusion: rhGH enhances body mass, does not stimulate tumor growth, and has no adverse effects on tumor bearing nude mice. Combined with flurouracil, rhGH does not influence the efficacy of chemotherapy, and has no effect on tumor cell cycle kinetics. 展开更多
关键词 stomach neoplasms/drug therapy mice nude recombined human growth hormone
下载PDF
黄连素+四联疗法治疗幽门螺杆菌阳性消化性溃疡的临床效果分析
5
作者 李毅 李坚 《中国现代药物应用》 2024年第15期80-82,共3页
目的探究黄连素(别称:盐酸小檗碱)与四联疗法联合用药方案治疗幽门螺杆菌(Hp)阳性消化性溃疡的临床效果,为临床医师选择合理用药方案提供参考。方法204例Hp阳性消化性溃疡患者为研究对象,采用随机数字表法分为对照组和观察组,每组102例... 目的探究黄连素(别称:盐酸小檗碱)与四联疗法联合用药方案治疗幽门螺杆菌(Hp)阳性消化性溃疡的临床效果,为临床医师选择合理用药方案提供参考。方法204例Hp阳性消化性溃疡患者为研究对象,采用随机数字表法分为对照组和观察组,每组102例。对照组患者接受常规四联疗法治疗,观察组采用黄连素与四联疗法联合治疗。比较两组患者症状改善时间、Hp清除率及复发率、临床治疗效果、不良反应发生率。结果观察组患者反酸、嗳气、腹痛消失时间与溃疡愈合时间分别为(2.95±0.51)、(3.85±0.44)、(5.65±0.88)、(8.74±0.85)d,较对照组的(4.35±0.85)、(6.85±0.61)、(7.51±1.38)、(12.45±1.28)d短(P<0.05)。观察组患者Hp清除率及复发率分别为96.1%、3.9%,对照组患者分别为80.4%、17.6%,两组比较,观察组患者Hp清除率高,复发率低(P<0.05)。观察组患者治疗总有效率为98.0%,对照组为90.2%,两组比较,观察组较高(P<0.05)。观察组患者不良反应发生率为2.0%(2/102),与对照组的3.9%(4/102)比较无差异(P>0.05)。结论对Hp阳性消化性溃疡患者实施四联疗法治疗时联合黄连素可以快速改善临床症状,提升治疗效果,同时还能提高Hp清除率,降低复发率,值得推广。 展开更多
关键词 幽门螺杆菌 消化性溃疡 黄连素 四联疗法 联合用药 临床疗效
下载PDF
Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis:Focus on underlying mechanisms and future perspectives
6
作者 Zihan Liu Han Liu +4 位作者 Jialing Cheng Hongliang Wang Yanfang Yang Jun Ye Yuling Liu 《Chinese Chemical Letters》 SCIE CAS CSCD 2024年第2期118-130,共13页
Ulcerative colitis(UC)is a common progressive inflammatory disease whose incidence has increased rapidly in recent years,and can develop into colorectal cancer in severe cases.There are currently no adequate or effect... Ulcerative colitis(UC)is a common progressive inflammatory disease whose incidence has increased rapidly in recent years,and can develop into colorectal cancer in severe cases.There are currently no adequate or effective treatments for UC due to the fact that some patients have found suboptimal results after repeated administration,while others have experienced adverse effects.With the rapid development of nanotechnology,developing innovative colon-targeting platforms is essential to improving efficacy,reducing side effects,and improving patient compliance.In this review,we summarize the pathophysiological characteristics of UC and the most recent status of numerous nanodrug delivery systems based on different targeting mechanisms in treating UC.Oral,intravenous,and rectal drug delivery nanoparticles targeting the colon are discussed,which can provide ideas for the design of colon-targeting nanoparticles for the treatment of colon diseases,especially for the treatment of UC.Last but not least,we provide a glimpse into the future of colon-targeted delivery systems,as well as future advancements in the field. 展开更多
关键词 ulcerative colitis Physiological characteristics Colon-specific drug delivery Mechanisms of action Targeted therapy of UC
原文传递
铋剂四联疗法联合针刺督脉背段压痛穴位治疗脾胃虚寒型Hp感染性胃溃疡疗效分析
7
作者 王小沙 刘青塬 《中国烧伤创疡杂志》 2024年第2期152-156,共5页
目的分析铋剂四联疗法联合针刺督脉背段压痛穴位治疗脾胃虚寒型幽门螺杆菌(Hp)感染性胃溃疡的临床疗效。方法选取2020年1月至2021年12月河南科技大学第一附属医院收治的80例脾胃虚寒型Hp感染性胃溃疡患者作为研究对象,按照不同治疗方法... 目的分析铋剂四联疗法联合针刺督脉背段压痛穴位治疗脾胃虚寒型幽门螺杆菌(Hp)感染性胃溃疡的临床疗效。方法选取2020年1月至2021年12月河南科技大学第一附属医院收治的80例脾胃虚寒型Hp感染性胃溃疡患者作为研究对象,按照不同治疗方法将其分为联合组(40例)与对照组(40例),联合组患者采用铋剂四联疗法联合针刺督脉背段压痛穴位治疗,对照组患者单纯采用铋剂四联疗法治疗,对比观察两组患者中医症候评分、溃疡长径、血清胃泌素(GAS)水平、Hp转阴率及临床疗效。结果治疗14 d后,联合组患者胃脘疼痛、食后腹胀、嗳气泛酸、恶心反胃评分以及血清GAS水平均明显低于对照组(t=6.910、6.318、7.140、9.345、8.819,P均<0.001),溃疡长径明显短于对照组(t=18.860,P<0.001);联合组患者Hp转阴率为87.5%,明显高于对照组患者的Hp转阴率67.5%(χ^(2)=4.588,P=0.032);联合组患者中显效26例、有效11例、无效3例,明显优于对照组患者的显效19例、有效10例、无效11例(Z=-1.997,P=0.046)。结论铋剂四联疗法联合针刺督脉背段压痛穴位治疗脾胃虚寒型Hp感染性胃溃疡,可明显降低GAS水平,提高Hp转阴率,改善患者脾胃虚寒症状,促进溃疡愈合。 展开更多
关键词 针刺 督脉背段 压痛穴位 铋剂四联疗法 Hp感染 胃溃疡 脾胃虚寒
下载PDF
沉香温胃丸对低温环境下胃溃疡的防治作用
8
作者 周琳梅 《中国医药指南》 2024年第30期137-140,共4页
目的 研究低温环境下胃溃疡防治中沉香温胃丸的应用价值。方法 于2023年4月至2024年3月选取大鼠进行动物实验,选取36只大鼠,根据管理方法分组,均匀分设6组,包括空白组、胃溃疡模型组(造模组)、奥美拉唑用药组(西药组)、低剂量中药组、... 目的 研究低温环境下胃溃疡防治中沉香温胃丸的应用价值。方法 于2023年4月至2024年3月选取大鼠进行动物实验,选取36只大鼠,根据管理方法分组,均匀分设6组,包括空白组、胃溃疡模型组(造模组)、奥美拉唑用药组(西药组)、低剂量中药组、中剂量中药组、高剂量中药组,其中中药3组均为沉香温胃丸用药,比较各组胃溃疡指数、血清白细胞介素6(IL-6)指标、胃黏膜蛋白浓度血清丙二醛(MDA)指标。结果 胃溃疡指数比较,造模组最高,用药4组较低,空白组最低(P <0.05)。血清IL-6指标比较,造模组IL-6指标较高(P <0.05),用药4组、空白组IL-6指标无统计学意义(P> 0.05)。蛋白浓度比较,造模组MDA指标较高,其次为用药4组,空白组最低(P <0.05),用药4组MDA指标无统计学意义(P> 0.05)。结论 沉香温胃丸可缓解大鼠胃溃疡病情,减轻局部炎性反应,改善胃溃疡指数,促进胃黏膜修复,疗效与西药奥美拉唑相近,应用价值较高。 展开更多
关键词 低温环境下胃溃疡 应激性溃疡 沉香温胃丸 药物实验 大鼠
下载PDF
消化内科胃及十二指肠溃疡药物治疗的临床疗效分析
9
作者 乔凤元 孔祥飞 《中国实用医药》 2024年第6期6-9,共4页
目的 探究消化内科胃及十二指肠溃疡药物治疗的临床效果。方法 80例胃及十二指肠溃疡患者,随机分为对照组和观察组,每组40例。对照组接受三联疗法进行治疗,观察组在对照组用药基础上加用枸橼酸铋钾治疗。对比两组患者临床疗效、幽门螺杆... 目的 探究消化内科胃及十二指肠溃疡药物治疗的临床效果。方法 80例胃及十二指肠溃疡患者,随机分为对照组和观察组,每组40例。对照组接受三联疗法进行治疗,观察组在对照组用药基础上加用枸橼酸铋钾治疗。对比两组患者临床疗效、幽门螺杆菌(Hp)清除率、不良反应发生率、满意度及生活质量评分。结果 观察组临床总有效率95.00%高于对照组的70.00%(P<0.05)。观察组患者Hp清除率97.50%高于对照组的72.50%,不良反应发生率15.00%低于对照组的37.50%(P<0.05)。治疗后,观察组患者躯体功能、社会功能、角色功能、认知功能评分分别为(77.88±6.96)、(79.81±7.85)、(86.94±6.88)、(86.58±6.77)分,均高于对照组的(64.14±6.19)、(65.18±7.22)、(73.19±5.33)、(75.20±6.41)分(P<0.05)。观察组患者总满意率为97.50%,高于对照组的72.50%(P<0.05)。结论 针对胃及十二指肠溃疡患者,在三联疗法基础上加用枸橼酸铋钾可显著提升患者临床疗效,提高Hp清除率,降低不良反应发生率,并且可以有效改善患者生活质量,增强患者满意度,值得临床推广应用。 展开更多
关键词 胃及十二指肠溃疡 消化内科 药物治疗 应用效果
下载PDF
抗体药物偶联物在人表皮生长因子受体2低表达胃癌中的应用研究进展
10
作者 康殷楠 石嘉琪 +4 位作者 王俊科 李斌 李初谊 马俊 于晓辉 《中国全科医学》 CAS 北大核心 2024年第18期2287-2294,共8页
胃癌(GC)是极具异质性和侵袭性的消化系统恶性肿瘤之一,传统化疗药物及曲妥珠单抗等人表皮生长因子受体2(HER2)靶向药物在GC的治疗过程中仍然存在耐药性发生率高、毒副作用大、患者耐受差等缺点。因此,研发更为有效的抗GC药物势在必行... 胃癌(GC)是极具异质性和侵袭性的消化系统恶性肿瘤之一,传统化疗药物及曲妥珠单抗等人表皮生长因子受体2(HER2)靶向药物在GC的治疗过程中仍然存在耐药性发生率高、毒副作用大、患者耐受差等缺点。因此,研发更为有效的抗GC药物势在必行。目前针对HER2的新型靶向药层出不穷,但在某些情况下无效或产生耐药,这与HER2在某些GC细胞中低表达有关,HER2低表达(HER2 IHC1+或IHC2+/ISH-)约占全部类型的40%~60%,但在临床实践中,这类患者仍被报告为HER2阴性GC。因此准确检测HER2表达状态对于确定可能受益于曲妥珠单抗治疗的患者至关重要。抗体药物偶联物(ADC)的出现为HER2阳性GC提供了新的治疗选择,凭借其精准高效的抗肿瘤作用,有望在未来替代传统GC化学疗法。近期有研究发现ADC可能在HER2低表达GC中具有潜在抗肿瘤活性,相关临床研究正在评估其在HER2低表达GC治疗中的有效性和安全性。本文就靶向治疗时代ADC在HER2低表达GC患者中的应用和最新研究进展作一综述,并讨论HER2靶向ADC在应用和研发过程中面临的挑战。 展开更多
关键词 胃肿瘤 胃癌 人表皮生长因子受体2 HER2低表达胃癌 抗体药物偶联物 分子靶向治疗 综述
下载PDF
疏肝和胃方联合四联疗法治疗肝胃气滞型胃溃疡临床观察
11
作者 刘生玲 《中国中医药现代远程教育》 2024年第15期146-149,共4页
目的探讨肝胃气滞型胃溃疡(GU)患者应用疏肝和胃方联合四联疗法的效果。方法采用随机数字表法将2020年1月—2022年3月萍乡市第二人民医院收治的60例GU患者分为两组,每组30例。对照组予以四联疗法,观察组在对照组的基础上加用自拟疏肝和... 目的探讨肝胃气滞型胃溃疡(GU)患者应用疏肝和胃方联合四联疗法的效果。方法采用随机数字表法将2020年1月—2022年3月萍乡市第二人民医院收治的60例GU患者分为两组,每组30例。对照组予以四联疗法,观察组在对照组的基础上加用自拟疏肝和胃方,两组均连续治疗4周。比较两组临床疗效、中医证候积分、炎症因子水平、胃肠激素水平、幽门螺杆菌(Hp)转阴率及不良反应。结果治疗后,观察组生长抑素(SS)水平及Hp转阴率较对照组高,各项中医证候积分及肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)、白细胞介素-6(IL-6)、胃泌素(GAS)水平较对照组低,差异均有统计学意义(P<0.05)。观察组临床总有效率93.33%(28/30)高于对照组的73.33%(22/30)(P<0.05)。两组均未见明显不良反应。结论疏肝理气联合四联疗法、和胃止痛法治疗肝胃气滞型GU患者可增强临床效果、减轻炎症反应、改善胃肠功能,且安全性好,值得推广。 展开更多
关键词 胃脘痛 胃溃疡 肝胃气滞证 疏肝理气法 和胃止痛法 四联疗法 中西医结合疗法
下载PDF
加味理中汤联合西药治疗消化性溃疡脾胃虚寒证29例
12
作者 刘生玲 《中国中医药现代远程教育》 2024年第17期152-154,共3页
目的探讨消化性溃疡(PU)脾胃虚寒证患者应用加味理中汤联合西药治疗的临床效果。方法采用随机数字表法将萍乡市第二人民医院2020年4月—2022年5月收治的58例PU患者分为两组,各29例。对照组给予常规西药治疗,观察组加用加味理中汤治疗,... 目的探讨消化性溃疡(PU)脾胃虚寒证患者应用加味理中汤联合西药治疗的临床效果。方法采用随机数字表法将萍乡市第二人民医院2020年4月—2022年5月收治的58例PU患者分为两组,各29例。对照组给予常规西药治疗,观察组加用加味理中汤治疗,比较两组临床疗效、中医证候积分、炎症因子水平、胃肠激素水平、生活质量及不良反应。结果观察组总有效率为93.10%(27/29),高于对照组的72.41%(21/29)(P<0.05)。治疗后,观察组中医证候积分及白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、胃泌素(GAS)水平较对照组低,胃动素(MTL)水平及生活质量评分较对照组高,差异均有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论PU脾胃虚寒证患者应用加味理中汤联合西药治疗,可抑制炎症反应,改善胃肠功能,减轻病痛,提升生活质量,效果显著,安全可靠,有利于预后。 展开更多
关键词 胃脘痛 消化性溃疡 脾胃虚寒证 理中汤 中西医结合疗法
下载PDF
浅析药穴指针治疗肝胃郁热型胃食管反流病
13
作者 梁才琳 李洁 《中医临床研究》 2024年第21期24-27,共4页
胃食管反流病(Gastroesophageal Reflux Disease,GERD)是常见的消化类疾病,临床上以反酸、烧心为主要表现,其中以肝胃郁热证型较为多见。药穴指针疗法在治疗GERD上有显著功效,它是在患者体表穴位将药物和指法相结合治疗的中医特色疗法... 胃食管反流病(Gastroesophageal Reflux Disease,GERD)是常见的消化类疾病,临床上以反酸、烧心为主要表现,其中以肝胃郁热证型较为多见。药穴指针疗法在治疗GERD上有显著功效,它是在患者体表穴位将药物和指法相结合治疗的中医特色疗法。指针是基于经络理论基础,通过在患者体表穴位和特定的刺激线上,运用点、按、拍、叩、捶等不同手法,促进机体功能恢复正常,治疗和预防疾病的一种治疗方法。能起到疏通经络、调和阴阳和扶正祛邪的功效。通过查阅文献总结发现,GERD的肝胃郁热证发病机制多为脾胃不足运化失司,导致水湿内停,日久郁而化热而发为本病。本研究通过查阅相关文献资料和临床收集严光俊教授治疗肝胃郁热型GERD的医案1例为GERD的临床研究提供参考。对中医药穴指针治疗GERD的中医理论、临床操作进行探索,深入剖析药针指穴治疗GERD的理论基础和作用机制,为临床运用药穴指针治疗GERD提供思路。 展开更多
关键词 胃食管反流病 药穴指针疗法 肝胃郁热证
下载PDF
四君子汤加减联合艾灸疗法治疗胃溃疡脾胃气虚证的临床效果
14
作者 朱精琪 《反射疗法与康复医学》 2024年第1期57-60,共4页
目的分析胃溃疡(GU)脾胃气虚证患者采用四君子汤加减联合艾灸疗法治疗的效果.方法选取2020年1月—2023年1月曹县人民医院收治的82例GU脾胃气虚证患者为研究对象,按随机数字表法将其分为对照组及观察组.对照组(n=41)采用艾灸疗法治疗,在... 目的分析胃溃疡(GU)脾胃气虚证患者采用四君子汤加减联合艾灸疗法治疗的效果.方法选取2020年1月—2023年1月曹县人民医院收治的82例GU脾胃气虚证患者为研究对象,按随机数字表法将其分为对照组及观察组.对照组(n=41)采用艾灸疗法治疗,在此基础上,观察组(n=41)采用四君子汤加减治疗.比较两组患者的中医证候积分、症状消失时间、血清炎症因子水平及溃疡愈合率.结果治疗后,观察组的中医证候积分为(16.43±3.48)分,低于对照组(19.76±3.31)分,差异有统计学意义(P﹤0.05).观察组的餐后饱腹感、早饱、上腹痛、嗳气消失时间分别为(1.46±0.25)d、(1.67±0.43)d、(2.05±0.62)d、(2.45±0.83)d,均短于对照组的(1.88±0.43)d、(1.96±0.48)d、(3.63±0.73)d、(3.66±0.91)d,组间差异有统计学意义(P﹤0.05).治疗后,观察组的白细胞介素-6、肿瘤坏死因子-α、转化生长因子-β1水平分别为(106.33±23.16)ng/mL、(51.64±6.67)pg/mL、(1.02±0.15)pg/mL,均低于对照组的(154.56±35.67)ng/mL、(63.54±7.35)pg/mL、(1.57±0.67)pg/mL,组间差异有统计学意义(P﹤0.05).观察组的溃疡总愈合率为90.24%,高于对照组的70.73%,差异有统计学意义(P﹤0.05).结论GU脾胃气虚证患者采用四君子加减与艾灸疗法治疗的效果显著,可快速缓解症状,减轻机体炎症反应,提升溃疡总愈合率,值得推广. 展开更多
关键词 胃溃疡 脾胃气虚证 四君子汤加减 艾灸疗法 中医证候积分 炎症因子
下载PDF
A study of preoperative methionine-depleting parenteral nutrition plus chemotherapy in gastric cancer patients 被引量:22
15
作者 Cao WX Cheng QM +3 位作者 Fei XF Li SF Yin HR Lin YZ 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第2期255-258,共4页
AIM To investigate the interference ofmethionine.free parenteral nutrition plus 5-Fu(-MetTPN+5-Fu)in gastric cancer cell kineticsand the side effects of the regimen.METHODS Fifteen patients with advancedgastric canc... AIM To investigate the interference ofmethionine.free parenteral nutrition plus 5-Fu(-MetTPN+5-Fu)in gastric cancer cell kineticsand the side effects of the regimen.METHODS Fifteen patients with advancedgastric cancer were randomly divided into twogroups,7 patients were given preoperatively aseven-day course of standard parenteralnutrition in combination with a five-day courseof chemotherapy(sTPN+5-Fu),while the other8 patients were given methionine-deprivedparenteral nutrition and 5-Fu(-MetTPN+5-Fu).Cell cycles of gastric cancer and normal mucosawere studied by flow cytometry(FCM).Bloodsamples were taken to measure the serumprotein,methionine(Met)and cysteine(Cys)levels,and liver and kidney functions.RESULTS As compared with the resultsobtained before the treatment,the percentage ofG<sub>0</sub>/G<sub>1</sub> tumor cells increased and that of S phasedecreased in the-MetTPN+5-Fu group,while thecontrary was observed in the sTPN+5-Fu group.Except that the ALT,AST and AKP levels wereslightly increased in a few cases receiving-MetTPN+5-Fu,all the other biochemicalparameters were within normal limits.Serum Cys level decreased slightly after the treatmentin both groups.Serum Met level of patientsreceiving sTPN+5-Fu was somewhat higher aftertreatment than that before treatment;however,no significant change occurred in the -MetTPN+5-Fu group,nor operative complications in bothgroups.CONCLUSION -MetTPN+5-Fu exerted asuppressive effect on cancer cell proliferation,probably through a double mechanism ofcreating a state of'Met starvation'adverse tothe tumor cell cycle,and by allowing 5-Fu to killspecifically cells in S phase.Preoperative short-term administration of -MetTPN+5-Fu had littleundesirable effect on host metabolism. 展开更多
关键词 stomach neoplasms/drug therapy METHIONINE PARENTERAL NUTRITION
下载PDF
Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin 被引量:24
16
作者 Cui HF Jiang XL 《World Journal of Gastroenterology》 SCIE CAS CSCD 1999年第5期448-450,共3页
关键词 COLITIS ulcerative/drug therapy heparin/therapertic use corticosteroidresistant
下载PDF
A clinical and long-term follow-up study of perioperative sequential triple therapy for gastric cancer 被引量:18
17
作者 Zou SC Qiu HS +1 位作者 Zhang CW Tao HQ 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第2期284-286,共3页
INTRODUCTIONAlthough the long-term postoperative survival rateof gastric cancer(GC) patients has been improvedsignificantly since the local dissection of lymph nodewas widely used in China,yet the low curativeresectio... INTRODUCTIONAlthough the long-term postoperative survival rateof gastric cancer(GC) patients has been improvedsignificantly since the local dissection of lymph nodewas widely used in China,yet the low curativeresection rate and the high recurrence rate fromperitoneal and hepatic metastases hinder it fromfurther improvement.To alter the currentunsatisfactory status of GC treatment,a 展开更多
关键词 stomach neoplasms/surgery stomach neoplasms/drug therapy INTRA-ARTERIAL CHEMOtherapy intra-peritoneal CHEMOtherapy CURATIVE resection survival rate
下载PDF
Auricular-Plaster Therapy Plus Acupuncture at Zusanli for Postoperative Recovery of Intestinal Function 被引量:7
18
作者 万茜 周永生 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2000年第2期134-135,共2页
In order to relieve the abdominal distension and other discomforts due to gastrointestinal dysfunction after abdominal operations, the patients were treated by auricular-plaster therapy plus acupuncture at Zusanli (ST... In order to relieve the abdominal distension and other discomforts due to gastrointestinal dysfunction after abdominal operations, the patients were treated by auricular-plaster therapy plus acupuncture at Zusanli (ST 36). 12 (92.4%) of the 13 cases in the treatment group showed recovery of normal peristalsis within 72 hours after operations, while that in 13 cases of the control group was 46.1%, indicating that auricular-plaster therapy plus acupuncture at Zusanli (ST 36) may promote postoperative recovery of the intestinal function. 展开更多
关键词 ACUPRESSURE Acupuncture therapy Adult Cholecystectomy CHOLECYSTITIS Female FLATULENCE GASTRECTOMY Humans Male Middle Aged PERISTALSIS Postoperative Period stomach Neoplasms stomach ulcer
下载PDF
Clinical characteristics of peptic ulcer perforation in Korea 被引量:4
19
作者 Young Joo Yang Chang Seok Bang +4 位作者 Suk Pyo Shin Tae Young Park Ki Tae Suk Gwang Ho Baik Dong Joon Kim 《World Journal of Gastroenterology》 SCIE CAS 2017年第14期2566-2574,共9页
AIM To elucidate the epidemiological characteristics and associated risk factors of perforated peptic ulcer(PPU).METHODS We retrospectively reviewed medical records of patients who were diagnosed with benign PPU from ... AIM To elucidate the epidemiological characteristics and associated risk factors of perforated peptic ulcer(PPU).METHODS We retrospectively reviewed medical records of patients who were diagnosed with benign PPU from 2010 through 2015 at 6 Hallym university-affiliated hospitals.RESULTS A total of 396 patients were identified with postoperative complication rate of 9.1% and mortality rate of 0.8%. Among 174(43.9%) patients who were examined for Helicobacter pylori(H. pylori) infection, 78(44.8%) patients were positive for H. pylori infection, 21(12.1%) were on non-steroidal anti-inflammatory drugs(NSAIDs) therapy, and 80(46%) patients were neither infected of H. pylori nor treated by any kinds of NSAIDs. Multivariate analysis indicated that older age(OR = 1.09, 95%CI: 1.04-1.16) and comorbidity(OR = 4.11, 95%CI: 1.03-16.48) were risk factors for NSAID-associated PPU compared with non-H. pylori, non-NSAID associated PPU and older age(OR = 1.04, 95%CI: 1.02-1.07) and alcohol consumption(OR = 2.08, 95%CI: 1.05-4.13) were risk factors for non-H. pylori, non-NSAID associated PPU compared with solely H. pylori positive PPU.CONCLUSION Elderly patients with comorbidities are associated with NSAIDs-associated PPU. Non-H. pylori, non-NSAID peptic ulcer is important etiology of PPU and alcohol consumption is associated risk factor. 展开更多
关键词 Helicobacter pylori Non-steroidal anti-inflammatory drugs Peptic ulcer perforation stomach ulcer Duodenal ulcer
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
20
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic USE cisapride/therapeutic USE peptic ulcer gastrointestinal motility
下载PDF
上一页 1 2 40 下一页 到第
使用帮助 返回顶部